Pharmaceutical manufacturer 🇨🇭, Switzerland
Roche is a healthcare company headquartered in Basel, Switzerland, with businesses in pharmaceuticals and diagnostics. It develops medicines and diagnostic tests across areas including cancer, neurological conditions and metabolic diseases. Its work in the GLP-1 market includes enicepatide, an experimental weekly injection being studied for obesity and type 2 diabetes.
Market cap not yet added.
Last 12 months
Last 12 months
Roche says its experimental weekly injection reduced weight and blood sugar in a mid-stage diabetes study. The results do not establish an advantage over rival medicines.
RocheGrow revenue at each location and build a commercial model that can scale across a clinic group.
Sanor never sells your personal information. By providing this information you agree to Sanor’s Privacy Policy and Terms of Service.
SANOR research follows the principles of ISO 20252:2019 and the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics, and is conducted in line with our Independence Policy. Our published reports follow our Editorial Standards.
SANOR research is funded through advisory engagements and research licensing. We do not accept vendor sponsorship, paid placement, or advertising.
All publications are provided for general information only. They do not constitute medical, financial, or investment advice and do not account for the circumstances of any specific business or individual.
